https://knews.kathimerini.com.cy/en/news/groundbreaking-cancer-study-by-cyprus-institute-of-neurology-and-genetics
Researchers from CING have published a new study in Cancers, offering significant insights for the accurate staging and early detection of multiple myeloma....
https://knews.kathimerini.com.cy/en/news/revolutionary-cancer-drug-kills-all-solid-tumors-leaves-healthy-cells-intact
Scientists have developed a holy grail cancer drug that kills all solid cancer tumors while leaving other cells unharmed....
https://knews.kathimerini.com.cy/en/news/promising-drug-slows-alzheimer-s-decline-by-36
A new drug that claims to slow mental decline caused by Alzheimer's by 36 percent could spell 'the beginning of the end' for the degenerative brain disease....
https://knews.kathimerini.com.cy/en/news/who-is-dr-robert-malone-and-what-is-the-controversy-surrounding-his-statements-on-mrna-vaccines
Robert Malone, the self-proclaimed inventor of mRNA vaccines and a skeptic of the COVID-19 vaccines that use mRNA technology, has skyrocketed to celebrity status in recent months....
https://knews.kathimerini.com.cy/en/news/op-ed-the-far-reaching-benefits-of-mrna-technology
The mRNA platform is a tantalizingly simple and transformative technology, scaling the scope of targeting diseases in ways that were previously unimaginable....
https://knews.kathimerini.com.cy/en/news/msd-pill-how-many-cypriots-received-it-and-how-many-were-hospitalized
More and more drugs are being included in doctors' inventories in order to deal with the pandemic. At the moment, at the European level, eight are available - pills and monoclonal antibodies - which Cyprus has taken care to secure....
https://knews.kathimerini.com.cy/en/news/monoclonal-antibody-treatment-for-covid-expected-in-cyprus-any-day-now
The arrival of monoclonal antibody therapies in Cyprus is just a matter of time, according to the Deputy Director of Pharmaceutical Services of the Ministry of Health, Dr. Elena Panagiotopoulou....
https://knews.kathimerini.com.cy/en/news/regeneron-antibody-cocktail-protects-for-up-to-eight-months
Regeneron reported that a dose of the antibody cocktail it makes reduced the risk of COVID-19 infection by 81.6% for two to eight months after administration of the drug in a final trial....
https://knews.kathimerini.com.cy/en/news/new-types-of-covid-vaccines-and-alternative-therapies
It's only a matter of time before Cyprus finalizes orders of new COVID vaccines and therapies. ...
https://knews.kathimerini.com.cy/en/news/astrazeneca-s-antibody-cocktail-successful-in-treating-covid-19
AstraZeneca has asked US regulators to grant an emergency use authorization for its antibody therapy drug called AZD7442....
https://knews.kathimerini.com.cy/en/news/stella-kyriakidou
The Commissioner for Health and Food Safety, Stella Kyriakides, will be in Cyprus on Friday, September 24, for meetings,...
https://knews.kathimerini.com.cy/en/news/ema-puts-covid-pill-review-on-fast-track
The European Medicines Agency says it has begun a rolling review of data on sotrovimab, an antibody cure for treating COVID-19, with European Commissioner Stella Kyriakides saying therapeutic solutions were also crucial alongside vaccinations...
https://knews.kathimerini.com.cy/en/news/eu-reaches-vaccine-deal-with-astrazeneca
The Cyprus-born EU Commissioner for Health and Food Safety announced Thursday the EU’s first vaccine deal, reached with the pharmaceutical company AstraZeneca, for a quantity of up to 400 million doses of the vaccine under development....
